Nucliq Biologics
1 known investors
Find your way into Nucliq Biologics
Nucliq Biologics analyzes the gut microbiome using AI, machine learning, and multi-omics science (metagenomics, transcriptomics, metabolomics) to identify microbial signatures and develop precision therapeutics. The company targets chronic, multifactorial diseases through therapies that modulate neuroimmune, gut-brain, and gut-skin axes.
Investors · 1
Frequently asked questions
- What does Nucliq Biologics do?
- Nucliq Biologics analyzes the gut microbiome using AI, machine learning, and multi-omics science (metagenomics, transcriptomics, metabolomics) to identify microbial signatures and develop precision therapeutics. The company targets chronic, multifactorial diseases through therapies that modulate neuroimmune, gut-brain, and gut-skin axes.
- Who are Nucliq Biologics's investors?
- Nucliq Biologics's investors include Women's Equity Lab.
